Clinical, Laboratorial, and Urodynamic Findings of Prostatic Artery Embolization for the Treatment of Urinary Retention Related to Benign Prostatic Hyperplasia. A Prospective Single-Center Pilot Study
dc.contributor | Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP | |
dc.contributor.author | ANTUNES, Alberto A. | |
dc.contributor.author | CARNEVALE, Francisco C. | |
dc.contributor.author | LEAL FILHO, Joaquim M. da Motta | |
dc.contributor.author | YOSHINAGA, Eduardo M. | |
dc.contributor.author | CERRI, Luciana M. O. | |
dc.contributor.author | BARONI, Ronaldo H. | |
dc.contributor.author | MARCELINO, Antonio S. Z. | |
dc.contributor.author | CERRI, Giovanni G. | |
dc.contributor.author | SROUGI, Miguel | |
dc.date.accessioned | 2013-09-23T16:37:36Z | |
dc.date.available | 2013-09-23T16:37:36Z | |
dc.date.issued | 2013 | |
dc.description.abstract | This study was designed to describe the clinical, laboratorial, and urodynamic findings of prostatic artery embolization (PAE) in patients with urinary retention due to benign prostatic hyperplasia (BPH). A prospective study of 11 patients with urinary retention due to BPH was conducted. Patients underwent physical examination, prostate specific antigen (PSA) measurement, transrectal ultrasound, and magnetic resonance imaging. International prostate symptom score (IPSS), quality of life (QoL), and urodynamic testing were used to assess the outcome before and after 1 year. Clinical success was 91 % (10/11 patients) with a mean follow-up of 22.3 months (range, 12-41 months). At the first year follow-up, the mean IPSS score was 2.8 points (p = 0.04), mean QoL was 0.4 points (p = 0.001), mean PSA decreased from 10.1 to 4.3 ng/mL (p = 0.003), maximum urinary flow (Qmax) improved from 4.2 to 10.8 mL/sec (p = 0.009), and detrusor pressure (Pdet) decreased from 85.7 to 51.5 cm H2O (p = 0.007). Before PAE, Bladder Outlet Obstruction Index (BOOI) showed values > 40 in 100 % of patients. After PAE, 30 % of patients were > 40 (obstructed), 40 % were between 20 and 40 (undetermined), and 30 % were < 20 (unobstructed). Patients with a BOOI < 20 had higher PSA values at 1-day after PAE. Clinical and urodynamic parameters improved significantly after PAE in patients with acute urinary retention due to BPH. Total PSA at day 1 after PAE was higher in patients with unobstructed values in pressure flow studies. | |
dc.description.index | MEDLINE | |
dc.identifier.citation | CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, v.36, n.4, p.978-986, 2013 | |
dc.identifier.doi | 10.1007/s00270-013-0611-5 | |
dc.identifier.issn | 0174-1551 | |
dc.identifier.uri | https://observatorio.fm.usp.br/handle/OPI/1897 | |
dc.language.iso | eng | |
dc.publisher | SPRINGER | |
dc.relation.ispartof | Cardiovascular and Interventional Radiology | |
dc.rights | restrictedAccess | |
dc.rights.holder | Copyright SPRINGER | |
dc.subject | Clinical practice | |
dc.subject | Imaging | |
dc.subject | Arterial intervention | |
dc.subject | Embolization/embolisation/embolotherapy | |
dc.subject | Endovascular treatment | |
dc.subject | Transcatheter therapy | |
dc.subject | MRI/MRA | |
dc.subject | Prostate | |
dc.subject | Urinary tract | |
dc.subject.other | bladder outlet obstruction | |
dc.subject.other | transurethral resection | |
dc.subject.other | massive hematuria | |
dc.subject.other | follow-up | |
dc.subject.other | management | |
dc.subject.other | hemorrhage | |
dc.subject.other | sape | |
dc.subject.other | turp | |
dc.subject.wos | Cardiac & Cardiovascular Systems | |
dc.subject.wos | Radiology, Nuclear Medicine & Medical Imaging | |
dc.title | Clinical, Laboratorial, and Urodynamic Findings of Prostatic Artery Embolization for the Treatment of Urinary Retention Related to Benign Prostatic Hyperplasia. A Prospective Single-Center Pilot Study | |
dc.type | article | |
dc.type.category | original article | |
dc.type.version | publishedVersion | |
dspace.entity.type | Publication | |
hcfmusp.citation.scopus | 79 | |
hcfmusp.contributor.author-fmusphc | ALBERTO AZOUBEL ANTUNES | |
hcfmusp.contributor.author-fmusphc | FRANCISCO CESAR CARNEVALE | |
hcfmusp.contributor.author-fmusphc | JOAQUIM MAURICIO DA MOTTA LEAL FILHO | |
hcfmusp.contributor.author-fmusphc | EDUARDO MURACCA YOSHINAGA | |
hcfmusp.contributor.author-fmusphc | LUCIANA MENDES DE OLIVEIRA CERRI | |
hcfmusp.contributor.author-fmusphc | RONALDO HUEB BARONI | |
hcfmusp.contributor.author-fmusphc | ANTONIO SERGIO ZAFRED MARCELINO | |
hcfmusp.contributor.author-fmusphc | GIOVANNI GUIDO CERRI | |
hcfmusp.contributor.author-fmusphc | MIGUEL SROUGI | |
hcfmusp.description.beginpage | 978 | |
hcfmusp.description.endpage | 986 | |
hcfmusp.description.issue | 4 | |
hcfmusp.description.volume | 36 | |
hcfmusp.origem | WOS | |
hcfmusp.origem.pubmed | 23580116 | |
hcfmusp.origem.scopus | 2-s2.0-84879898557 | |
hcfmusp.origem.wos | WOS:000321265000015 | |
hcfmusp.publisher.city | NEW YORK | |
hcfmusp.publisher.country | USA | |
hcfmusp.relation.reference | Abrams P, 1999, BJU INT, V84, P14 | |
hcfmusp.relation.reference | Antunes Alberto Azoubel, 2006, Clinics (Sao Paulo), V61, P545, DOI 10.1590/S1807-59322006000600010 | |
hcfmusp.relation.reference | APPLETON DS, 1988, BRIT J UROL, V61, P45, DOI 10.1111/j.1464-410X.1988.tb09160.x | |
hcfmusp.relation.reference | Barbieri A, 2002, UROL INT, V69, P318, DOI 10.1159/000066115 | |
hcfmusp.relation.reference | BISCHOFF W, 1977, UROLOGE A, V16, P99 | |
hcfmusp.relation.reference | Carnevale FC, 2011, CARDIOVASC INTER RAD, V34, P1330, DOI 10.1007/s00270-011-0136-8 | |
hcfmusp.relation.reference | Carnevale FC, 2010, CARDIOVASC INTER RAD, V33, P355, DOI 10.1007/s00270-009-9727-z | |
hcfmusp.relation.reference | Carnevale FC, 2013, J VASC INTERV RADIOL, V24, P535, DOI 10.1016/j.jvir.2012.12.019 | |
hcfmusp.relation.reference | Cross MJ, 2001, TRENDS PHARMACOL SCI, V22, P201, DOI 10.1016/S0165-6147(00)01676-X | |
hcfmusp.relation.reference | DeMeritt JS, 2000, J VASC INTERV RADIOL, V11, P767, DOI 10.1016/S1051-0443(07)61638-8 | |
hcfmusp.relation.reference | Jeon GS, 2009, J VASC INTERV RADIOL, V20, P384, DOI 10.1016/j.jvir.2008.11.014 | |
hcfmusp.relation.reference | Madersbacher S, 2004, EUR UROL, V46, P547, DOI 10.1016/j.eururo.2004.07.016 | |
hcfmusp.relation.reference | McVary KT, 2011, J UROLOGY, V185, P1793, DOI 10.1016/j.juro.2011.01.074 | |
hcfmusp.relation.reference | McVary KT, 2006, AM J MANAG CARE, V12, P122 | |
hcfmusp.relation.reference | Michel F, 2002, J UROLOGY, V168, P2550, DOI 10.1097/01.ju.0000036371.49460.7d | |
hcfmusp.relation.reference | Milord RA, 2000, AM J SURG PATHOL, V24, P1378, DOI 10.1097/00000478-200010000-00007 | |
hcfmusp.relation.reference | MITCHELL ME, 1976, J UROLOGY, V115, P692 | |
hcfmusp.relation.reference | Muzzonigro G, 2004, J UROLOGY, V172, P611, DOI 10.1097/01.ju.0000131258.36966.dI | |
hcfmusp.relation.reference | Nadalini V F, 1981, Radiol Med, V67, P61 | |
hcfmusp.relation.reference | Pisco JM, 2011, J VASC INTERV RADIOL, V22, P11, DOI 10.1016/j.jvir.2010.09.030 | |
hcfmusp.relation.reference | Rassweiler J, 2006, EUR UROL, V50, P969, DOI 10.1016/j.eururo.2005.12.042 | |
hcfmusp.relation.reference | Rastinehad AR, 2008, UROLOGY, V71, P181, DOI 10.1016/j.urology.2007.09.012 | |
hcfmusp.relation.reference | Schafer W, 2002, NEUROUROL URODYNAM, V21, P261, DOI 10.1002/nau.10066 | |
hcfmusp.relation.reference | Sun F, 2008, RADIOLOGY, V246, P783, DOI 10.1148/radiol.2463070647 | |
hcfmusp.relation.reference | Tan L, 2009, NAT REV UROL, V6, P680, DOI 10.1038/nrurol.2009.215 | |
hcfmusp.scopus.lastupdate | 2024-04-12 | |
relation.isAuthorOfPublication | 1e8c7153-c3dc-4c8f-8bf8-5e004f275e35 | |
relation.isAuthorOfPublication | 2ce53f16-d56a-4243-bb83-8fbac9c3189e | |
relation.isAuthorOfPublication | 1e71ee13-4ae0-4128-8b3f-19fdc3c9f9b2 | |
relation.isAuthorOfPublication | 9647b375-bd2a-4a6b-96ec-2658b78f13f8 | |
relation.isAuthorOfPublication | 0feb5bad-7412-40af-921c-64ff5fe8ee18 | |
relation.isAuthorOfPublication | 7eee5d61-7530-40cf-8ec0-b3709672d076 | |
relation.isAuthorOfPublication | bdd72d9b-e7b3-464f-982e-33ebb3e2135e | |
relation.isAuthorOfPublication | 639bdb47-6864-4462-951e-519181ec7bfd | |
relation.isAuthorOfPublication | cff561dd-5732-4af5-abe9-538da0cdf4d2 | |
relation.isAuthorOfPublication.latestForDiscovery | 1e8c7153-c3dc-4c8f-8bf8-5e004f275e35 |
Arquivos
Pacote Original
1 - 1 de 1
Nenhuma Miniatura disponível
- Nome:
- art_ANTUNES_Clinical_Laboratorial_and_Urodynamic_Findings_of_Prostatic_Artery_2013.PDF
- Tamanho:
- 494.26 KB
- Formato:
- Adobe Portable Document Format
- Descrição:
- publishedVersion (English)
Coleções
Artigos e Materiais de Revistas Científicas - FM/MDR
Artigos e Materiais de Revistas Científicas - FM/MCG
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - HC/InCor
Artigos e Materiais de Revistas Científicas - HC/InRad
Artigos e Materiais de Revistas Científicas - LIM/44
Carregar mais Artigos e Materiais de Revistas Científicas - FM/MCG
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - HC/InCor
Artigos e Materiais de Revistas Científicas - HC/InRad
Artigos e Materiais de Revistas Científicas - LIM/44